Not all fierce-looking dinosaurs like T rex packed strong bites, study reveals
Researchers, including from the University of Bristol, found that while dinosaurs like the mighty Tyrannosaurus rex were optimised for quick, strong bites, much like a crocodile, many others that walked on two legs, such as the spinosaurus and allosaurs, had much weaker bite forces and instead specialised in slashing and ripping flesh.
The research, published in the journal Current Biology, revealed that meat-eating dinosaurs followed different evolutionary paths in terms of skull design and feeding style despite their similarly gigantic sizes.
'Tyrannosaurs evolved skulls built for strength and crushing bites while other lineages had comparatively weaker but more specialized skulls, suggesting a diversity of feeding strategies even at massive sizes,' Andrew Rowe, one author of the study from the University of Bristol, said.
'In other words, there wasn't one 'best' skull design for being a predatory giant; several designs functioned perfectly well.'
In the study, scientists probed how walking on two legs influenced skull mechanics and feeding techniques in dinosaurs.
Previous research showed that despite reaching similar sizes, predatory dinosaurs evolved in very different parts of the world at various times and conditions and had different skull shapes.
This raised doubts on whether the skulls of these dinosaurs were functionally similar under the surface or if there were notable differences in their predatory lifestyles.
'Carnivorous dinosaurs took very different paths as they evolved into giants in terms of feeding biomechanics and possible behaviors,' Dr Rowe said.
To understand the relationship between body size and skull biomechanics, researchers used 3D X-ray scanning technology to analyse the skull mechanics and quantify the feeding performance and the bite strength across 18 species of two-legged carnivorous dinosaurs ranging from small ones to giants.
Researchers were surprised to find clear divergence among the species. For instance, skull stress didn't show a pattern of increase with size.
Some smaller dinosaurs even experienced greater stress than the larger species due to increased muscle volume and bite force.
'Tyrannosaurids like T rex had skulls that were optimised for high bite forces at the cost of higher skull stress,' Dr Rowe noted. 'But in some other giants like Giganotosaurus, we calculated stress patterns suggesting a relatively lighter bite. It drove home how evolution can produce multiple 'solutions' to life as a large, carnivorous biped.'
Overall, being a predatory two-legged dinosaur did not always equate to being a bone-crushing giant like T rex. Unlike T rex, some dinosaurs like spinosaurus and allosaurs became giants while maintaining weaker bites more suited to slashing at prey and stripping flesh.
'Large tyrannosaur skulls were instead optimised like modern crocodiles with high bite forces that crushed prey,' Dr Rowe explained. 'I tend to compare Allosaurus to a modern Komodo dragon in terms of feeding style.'
'This biomechanical diversity suggests that dinosaur ecosystems supported a wider range of giant carnivore ecologies than we often assume,' he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
22 minutes ago
- Telegraph
Parts of David Attenborough's latest series filmed in fish tank, BBC admits
The BBC has admitted that part of Sir David Attenborough's latest nature series was filmed in specialist 'tanks' rather than in the wild. Key segments in the corporation's new Parenthood series, narrated by Sir David, could not be filmed 'in situ' in order to protect the species involved, according to the producers. Skeleton shrimp, boxer crabs and Banggai cardinalfish were among the animals filmed in 'a specialist filming environment' to ensure family bonds and habitats were not disturbed. Specialist tanks and 'incubation units' were therefore used – in part – to help the BBC capture 'the intimate relationships between parent and their offspring '. Jeff Wilson, the series producer and director, and Olly Scholey, its producer, insisted that the balance in these relationships could 'be easily upset' by interference. Writing in an online article about the series for the BBC, they explained: 'In the world of wildlife filmmaking, affecting the behaviour of your subjects is a line we work hard not to cross, and these parenting relationships are incredibly fragile. 'In many cases, across the series, we are also dealing with species that are no bigger than a thumbnail … [meaning] that we needed to design the sequences with specific macro-technologies and careful use of light. 'So often, teams filming in these situations needed to tread carefully, or in this case, paddle carefully – and at times, we were forced to use specialist filming tanks to ensure that we got the balance absolutely right.' One such example featured in the opening of the Freshwater episode, which sees hundreds of thousands of Amazon river turtle hatchlings following their mothers to the water. However, the moment of actual hatching could not be captured in the wild because of the 'sensitive condition of the unhatched eggs underground'. 'To do so would mean risking the survival of the young themselves,' Wilson and Scholey explained. Instead, the filming crew for the natural history series worked 'hand-in-hand' with Brazilian scientific researchers and their incubation unit to 'create a specialist environment' where hatching could be captured. Similarly, producers needed to create 'a specialist filming environment' of see-through tanks to tell the parenting stories of skeleton shrimps as well as Banggai cardinalfish. Previous fakery claims The decision to film in specialist tanks rather than disrupt the animals' natural habitats follows wildlife filming's unofficial non-intervention rule. The BBC has previously been embroiled in accusations of fakery in its natural history documentaries, including a Frozen Planet sequence in 2011 in which a polar bear appeared to give birth in the Arctic, but was in fact filmed in a Dutch zoo. The corporation also admitted that a sequence filmed for an episode of Human Planet, also in 2011, misled viewers by giving the impression the tallest treehouses built by Papua New Guinea's Korowai people were used as homes. However, the broadcaster has said since these incidents it has strengthened training for its Natural History Unit in 'editorial guidelines, standards and values'.
Medical News Today
37 minutes ago
- Medical News Today
Popular artificial sweetener may negatively affect cancer immunotherapy
Non-sugar, or artificial, sweeteners are widely used to reduce the energy in sweetened foods and drinks, particularly those marketed as diet, or low or no concerns about their possible health effects include links to gastrointestinal problems, metabolic effects, and even increased cancer a study has found that one of the most widely used artificial sweeteners, sucralose, could adversely affect cancer researchers suggest that by changing the gut microbiome, sucralose decreases the effectiveness of immunotherapy for several cancers. Health concerns regarding sucralose have mainly centered around its potential to cause systemic inflammation, metabolic diseases, disruptions in gut microbiota, liver damage, and toxic effects at the cellular a study suggests that people whose diet includes large amounts of sucralose, e.g., from diet drinks, respond less well to cancer immunotherapy than those who consume less or none of the research, which is published in Cancer Discovery, a journal of the American Association of Cancer Research, found that sucralose changed the gut microbiota so bacteria degraded an amino acid, arginine, that immune cells need to be able to destroy cancer are experts worried about sucralose?Sucralose is one of six non-sugar sweeteners approved by the Food and Drug Administration (FDA) for use as additives in the food and drinks industry — the others are aspartame, advantame, neotame, saccharin, and acesulfame potassium (Ace-K).It is made by replacing 3 hydroxyl (oxygen and hydrogen) groups in sucrose (table sugar) molecules with chloride resulting sucralose is up to 650 times sweeter than sucrose and, because people cannot digest it, contains no accessible energy. Therefore, it is widely used to sweeten foods and drinks, as well as being sold as an alternative to sugar for those trying to decrease their energy intake. However, there are concerns, both about its health effects and its efficacy for helping weight loss. In 2023, the World Health Organization (WHO) advised that non-sugar sweeteners should not be used for weight control, saying that: 'Replacing free sugars with NSS [non-sugar sweeteners] does not help with weight control in the long term. […] NSS are not essential dietary factors and have no nutritional value. People should reduce the sweetness of the diet altogether, starting early in life, to improve their health.'Investigating the sucralose-cancer linkDiwakar Davar, MD, associate professor of medicine at the University of Pittsburgh and a medical oncologist and hematologist at UPMC Hillman Cancer Center, senior author of the study, told Medical News Today:'We think this finding is highly significant as it could have immediate positive impacts on cancer patients receiving immunotherapy. The fact that we not only identified sucralose as a potential problem for those receiving immunotherapy, but that we also found a way to fix this problem through arginine supplementation is exciting and something that could be put into clinical practice easily.'According to Jack Jacoub, MD, a board certified medical oncologist and medical director of MemorialCare Cancer Institute at Orange Coast and Saddleback Medical Centers in Orange County, CA, who was not involved in this research, the findings were significant.'Frankly, this is a superb piece of scientific work,' Jacoub told MNT. 'The authors were able to study preclinical models (mice) and draw conclusions related to the effect of high sucralose intake on T-cell function tumor response to immunotherapy.''They then took this understanding and later tested it in prospective enrolled patients with lung cancer and melanoma. They showed that patients consuming sucralose greater than 0.16 mg/kg/d [milligram per kilogram per day] had inferior response to immunotherapy,' he explained.'Recognizing the significance of arginine on T cell functions they then went back to the mouse model and proved giving it restored T cell function and benefit to immunotherapy in mice. In my opinion, this is high quality evidence suggesting this absolutely needs more exploration,' added decreased immune responseIn their study, the researchers included 132 patients who had undergone immunotherapy or chemoimmunotherapy for advanced/metastatic melanoma or advanced non-small cell lung cancer (NSCLC). They also included 25 patients who had high-risk resectable melanoma. All participants had completed a Diet History Questionnaire III (DHQ III), had received at least 3 months of treatment, had at least one post-treatment imaging study evaluable for response and had been followed up for at least 6 months from the start of the diet questionnaire, researchers calculated each patient's non-nutritive sugar (NNS) intake (mg/day) and divided it by their weight in kg to get a weight-normalized average daily intake of mg/kg/ with melanoma or non-small cell lung cancer who consumed high levels of sucralose (more than 0.16mg/kg/day) had a worse response to immunotherapy, and poorer survival rates, than those with diets low in the artificial whether people undergoing cancer immunotherapy should try to avoid sucralose in their diets, lead author Abby Overacre, PhD, assistant professor in the Department of Immunology at the University of Pittsburgh and UPMC Hillman Cancer Center, told MNT:'We are working on future prospective clinical trials to ask these sorts of questions for patients undergoing immunotherapy. Based on what we know so far, we would recommend that patients minimize intake of non-nutritive sweeteners, particularly sucralose.'Jacoub agreed with this assessment, saying that: 'This is enough information for me to recommend this to my patients. Frankly, we are talking about cancer and giving up diet soda, etc. is not difficult and directly goes to the question patients and their family commonly ask every day when I see them which is 'What can I do to help treat my cancer?'.'It is important to note that the research is still in the early stages, and this may not apply to all cancer microbiota changes reduced T-cell activityThe researchers then carried out tests in two mouse models of cancer to determine how high sucralose consumption reduced the immunotherapy found that mice fed sucralose were resistant to immunotherapy, had significantly increased tumor growth, less CD8+ T cell infiltration, and were more likely to T-cells are immune cells that produce the most powerful anti-cancer response, so their reduced function meant the immunotherapy was less effective. In the sucralose-fed mice, the researchers discovered changes in the gut microbiota, with greater numbers of gram positive bacteria that degraded arginine, an amino acid that is essential for T-cell production.'Gram positive bacteria have been associated with poorer immunotherapy efficacy in previous studies. However, we are very focused and interested in the function of these bacteria in hopes to better understand how they may directly contribute to cancer growth and immunotherapy response.'— Abby Overacre, PhDArginine supplements may counteract sucralose's effectsWhen researchers fed arginine or citrulline (which is metabolized in the body to arginine) to the mice, immunotherapy became effective again. They suggest that arginine or citrulline supplements could be given to people undergoing cancer immunotherapy to counteract the effect of sucralose in their diet. But could people undergoing cancer immunotherapy get enough arginine from their diet?'While there are certainly foods that are higher in arginine, especially in diets associated with better immunotherapy responses (nuts/seeds, poultry, lentils, fruits), a supplement may help those who struggle to achieve a high amount or arginine from diet alone,' Overacre told addition to continuing their research into sucralose and immunotherapy, the researchers hope to investigate whether other non-nutritive sweeteners have similar effects.'We hope that this study can help patients currently receiving immunotherapy. Importantly, this gives patients something they can do themselves or alongside their physicians to potentially improve their overall care.'— Abby Overacre, PhD
The Independent
2 hours ago
- The Independent
Experts reveal potential unintended side effect of Ozempic – and whether we should worry
The use of weight-loss jabs in the UK has skyrocketed, with an estimated 1.5 million people using them. Yet drugs like Ozempic and Wegovy don't just help people lose fat, but potentially muscle too, new research has suggested. A study that tested weight loss jabs on mice found that although muscle mass changes less than expected, muscles still get weaker and tissues like the liver also shrink. Weight-loss injections, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. The medications, known as semaglutides, predominantly treat diabetes but are also available on the NHS or via private providers to help adults with a high body mass index (BMI). For example, although Ozempic is used for type 2 diabetes, it is sometimes prescribed off-label as a weight-loss drug. The results of the study, published in the journal Cell Metabolism, revealed Ozempic -induced weight loss decreased muscle mass by about 10 per cent. Most of this lost weight wasn't from skeletal muscles, which surround bones and joints, but instead from other tissues like the liver, which shrank by nearly half. However, because the Ozempic was tested on mice, researchers emphasise that more research is needed to determine whether similar changes to organ size occur in humans and whether those changes come with any risks. 'Loss of mass in metabolically active organs, such as the liver, is expected as part of healthy weight loss,' said Dr Ran Hee Choi, research instructor in nutrition and integrative physiology at the University of Utah college of health, and co-first author on the study. In both mice and humans, weight gain and loss can affect the size of organs like the liver without affecting their function. 'It's unlikely that the observed lean mass loss represents a serious adverse effect,' added Dr Takuya Karasawa, another co-first author on the study. Researchers found some skeletal muscles did shrink by about 6 per cent as the mice lost weight, but not enough to explain the overall muscle loss. However, when someone gains fat, they also tend to gain skeletal muscle. Study authors explain this is because the body needs to work harder to move around. As a result, losing extra fat can lead to a loss of muscle, which will not affect the person's overall quality of life. Researchers also tested the amount of force the mice's muscles exerted and found that some muscle strength decreased as the mice lost weight, even when the size of the muscle stayed roughly the same. This potential loss of strength when taking Ozempic could be a particular concern for adults over the age of 60 who are at a higher risk of muscle loss and reduced mobility. 'The loss of physical function is a strong predictor of not just quality of life but longevity,' added Dr Katsu Funai, professor of nutrition at the University of Utah and the senior author on the study. Dr Funai concluded that further clinical trials of weight loss jabs should check for changes in muscle strength. A spokesperson for Novo Nordisk, which makes Ozempic, said: 'In clinical trial for Wegovy or Ozempic we did not specifically study the medicine's impact on muscle mass. In a sub-study of 140 patients with a BMI of 40 or less, analysis suggested that treatment with Wegovy was accompanied by reductions in both fat and lean body mass, with a greater reduction in fat mass than lean body mass. 'We recommend that any patients experiencing side effects while taking Wegovy or Ozempic contact their healthcare provider.'
